Related Experiment Video
Updated: Jul 12, 2025

09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
2.6K
Childhood cancer data initiative: Status report.
Subhashini Jagu1, Elaine R Mardis2, Mary F Wedekind3
1Office of Data Sharing, Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, Maryland, USA.
Pediatric Blood & Cancer
|October 27, 2023
Summary
The National Cancer Institute
Area of Science:
- Pediatric Oncology
- Cancer Data Science
- Bioinformatics
Background:
- The pediatric oncology community convened in March 2023 to assess the National Cancer Institute's Childhood Cancer Data Initiative.
- Progress in data ecosystem development and key programs was discussed by over 800 stakeholders.
- Current efforts focus on improving childhood cancer data accessibility and analysis.
Purpose of the Study:
- To present the current status of the Childhood Cancer Data Initiative's data ecosystem.
- To provide updates on significant programs, including the Molecular Characterization Initiative.
- To outline plans for the Coordinated National Initiative for Rare Cancers in Children and Young Adults.
Main Methods:
- A meeting of over 800 researchers, clinicians, patients, survivors, and advocates.
- Review of the progress and status of the Childhood Cancer Data Initiative.
- Discussion of specific programs and future initiatives.
Main Results:
- The Childhood Cancer Data Initiative is actively building its data ecosystem.
- Key programs like the Molecular Characterization Initiative are advancing.
- A new Coordinated National Initiative for Rare Cancers in Children and Young Adults is planned.
Conclusions:
- These initiatives aim to enhance childhood cancer data access and foster collaboration.
- Integrative data analysis and expanded molecular characterization are key objectives.
- The ultimate goal is to accelerate the development of novel therapeutic strategies for pediatric cancers.
Related Concept Videos
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Prevalence and Incidence
585
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
585

